Aurinia Pharmaceuticals (GB:0UJF)

Aurinia Pharmaceuticals (GB:0UJF) Cash flow


Aurinia Pharmaceuticals Cash Flow

GB:0UJF's free cash flow for Q2 2022 was $-27.79M. For the 2022 fiscal year, GB:0UJF's free cash flow was decreased by $-81.99M and operating cash flow was $-27.87M. See a summary of the company’s cash flow.
Cash Flow
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
$ -140.79M$ -157.69M$ -69.86M$ -63.59M$ -51.61M$ -41.17M
Investing Cash Flow
$ -45.69M$ -103.87M$ -158.19M$ 7.78M$ -65.00K$ -8.00M
Financing Cash Flow
$ 216.55M$ 221.11M$ 194.38M$ 243.85M$ 4.01M$ 175.15M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 573.66M$ 231.90M$ 272.35M$ 306.02M$ 117.97M$ 165.63M
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
$ 21.00K$ 257.00K$ 261.00K$ 59.00K$ 0.00-
Issuance Of Capital Stock
$ 196.74M$ 196.74M$ 187.73M$ 223.12M$ 0.00-
Issuance Of Debt
Repayment Of Debt
---$ -127.00K$ 0.00-
Free Cash Flow
$ -140.89M$ -159.19M$ -77.20M$ -63.69M$ -51.69M$ -41.19M
Domestic Sales
Foreign Sales
Currency in USD

Aurinia Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis